Suzette Hill
Examine other medical specialties for dermatologic answers
North Adelaide, Australia — In some selected Aboriginal communities in Australia's Northern Territory, up to 25 percent of adults and 50 percent of children may have scabies today — more than 100 years after the medical community claimed to master its diagnosis and cure, says Lachlan Warren, M.D., a dermatologist at Women's & Children's Hospital here.
Look to Cells, not Site, to Diagnose B-Cell Lymphoma
Because morphology, bcl-2 expression and multicentricity are the strongest predictive factors in multivariate analysis of PCDLBCL, Dr. Ellis proposes that primary subdivision of PCBCL according to anatomic location be abandoned in favor of classification by centroblast/immunoblast morphology.
For optimal result, begin treating with biologic while tapering conventional systemic therapy
Dallas — For psoriasis patients just starting treatment, as well as those who've had poor results from conventional systemic therapies, biologics are a good first-line treatment option. But what about those who've had good results with methotrexate and cyclosporine and are forced to consider alternatives?
Remicade does well in study on inflammation
Washington, D.C. - In a recent 10-week, three-dose phase II trial of inflaximab (Remicade), 87.9 percent of the 250 participants achieved PASI 75, while 58 percent achieved PASI 90 at the 10-week mark.
Pimecrolimus cream 1 percent shows less systemic absorption than tacrolimus 0.1 percent in treatment of atopic dermatitis
Washington - In the treatment of moderate-to-severe atopic dermatitis, pimecrolimus (Elidel) cream 1 percent is less likely than tacrolimus (Protopic) ointment 0.1 percent to be systemically absorbed, said Zoe Draelos, M.D., lead investigator of a blind treatment trial that compared systemic exposure levels of the two topical drugs.
PAs a growing factor as part of derm teams
Washington - Over the past three years, the ranks of dermatology physician assistants (PAs) have swelled, growing from approximately 600 in number to approximately 1,500, estimates Robert Higham, a dermatology PA at Mid Valley Dermatology in Sherman Oaks, Calif.
Drug exposure tested
Washington -- In the treatment of moderate-to-severe atopic dermatitis, pimecrolimus (Elidel) cream 1 percent is less likely than tacrolimus (Protopic) ointment 0.1 percent to be systemically absorbed, according to Zoe Draelos, M.D., lead investigator of a blind treatment trial that compared systemic exposure levels of the two topical drugs.
Less AD in adult populations
Anaheim Hills, Calif. - The new topical immunomodulators (TIMs) such as pimecrolimus (Elidel) and tacrolimus (Protopic) will reverse the growing number of cases of adult atopic dermatitis, predicts Cheryl Effron, M.D., a dermatologist in Anaheim Hills, Calif.
Turn Back the Clock
Philadelphia - Of all the cosmetic procedures that make hands appear younger, sclerotherapy delivers the most dramatic, long-lasting results, according to Lee Schulman, M.D., a phlebologist at Schulman Vein and Laser Center in New York City.
Relieve Psoriasis Symptoms
Las Vegas - Biologics, an emerging class of drugs derived from human and animal proteins, are providing effective, long-term relief to patients with moderate-to-severe psoriasis, says Mark Lebwohl, M.D., Soi and Clara Kest professor and chairman, department of dermatology, The Mount Sinai School of Medicine.

Poll

View Results